Sage Therapeutics cuts most of its workforce after planned acquisition

Sage Therapeutics is shedding most of its workers after asserting its deliberate acquisition earlier this month.

The Cambridge, Mass.-based biotech agency will minimize 338 jobs efficient Aug. 22, in keeping with state filings. In February, the corporate reported using 353 full-time employees, together with 122 working in analysis and improvement.

Discover of the layoffs, filed on June 26, got here lower than two weeks after Sage introduced it will be acquired by Maryland-based Supernus Prescribed drugs in a deal that might be price as much as $795 million.